Miguel SPE; Niño PA

Language: Spanish
References: 18
Page: 84-92
PDF size: 105.89 Kb.

ABSTRACT

The obesity is a serious health problem causing severe damages to the organism, with a decrease of the hope and quality of life. It is a basic component of the metabolic syndrome, especially the central obesity. It is prevented and treated with changes in the lifestyles including hypocaloric diets and increment of the physical activity. In present paper the main consequences of this chronic illness will be described.

REFERENCES

1. Redinger RN. The prevalence and etiology of nongenetic obesity and associated disorders. South Med J. 2008;101(4):395-99.

2. Hernández Triana M, Ruiz Álvarez V. Obesidad, una epidemia mundial. Implicaciones de la genética. Rev Cubana Invest Biomed. 2007;26(2). Disponible en http://bvs.sld.cu/revistas/ibi/indice.html [Consultado: 15 de septiembre de 2009].

3. Markoff B, Amsterdam A. Impact of obesity on hospitalized patients. Mt Sinai J Med. 2008;75:4549.

4. Russell L, Allen B. Obesity and You. South Med J.2008;101(4):337.

5. Danielsson G, Eklof B, Grandinetti A, Kistner RL. The influence of obesity on chronic venous disease. Vasc Endovasc Surg. 2002;36(4):271-6.

6. Björntorp P. Obesity: a chronic disease with alarming prevalence and consequences. J Intern Med. 1998;244:2679.

7. Poulain M, Doucet M, Major GC, Drapeau V, Sériès F, Boulet LP, et. al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ. 2006;174(9):1293-9.

8. Canöz M, Erdenen F, Uzun H, Müderrisglu C, Aydin S. The relationship of inflammatory cytokines with asthma and obesity. Clin Invest Med. 2008;31(6):E373-E379.

9. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14(3-4):222-31.

10. Miguel Soca PE. El síndrome metabólico: un alto riesgo para individuos sedentarios. Acimed. 2009;20(2). Disponible en: http://bvs.sld.cu/revistas/aci/vol20_2_09 /aci07809.htm [Consultado: 15 de septiembre de 2009].

11. Rodríguez Scull LE. La obesidad y sus consecuencias clinicometabólicas. Rev Cubana Endocrinol. 2004;15(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561 -29532004000300008&lng=es&nrm=iso&tlng=es [Consultado: 9 de septiembre de 2009].

12. Power C, Miller SK, Alpert PT. Promising new causal explanations for obesity and obesity-related diseases. Biol Res Nurs. 2007;8(223). Disponible en: http://brn.sagepub.com/cgi/content/abstract/8/3/223 [Consultado: 10 de septiembre de 2009].

13. Bray GA. Obesity is a chronic, relapsing neurochemical disease. Int J Obes. 2004;28:348.

14. Yildiz BO, Knochenhauer ES, Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endo Metab. 2008;93 (1):162-8.

15. Thomann R, Rossinelli N, Keller U, Tirri BF, De Geyter C, Ruiz J, Kranzlin M, Puder JJ. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome. Gynecol Endocrinol. 2008;24(4):199206.

16. Peña Sisto M, Peña Sisto L, Díaz Felizola A, Torres Keiruz D, Lao Salas N. La enfermedad periodontal como riesgo de enfermedades sistémicas. Rev Cubana Estomatol. 2008; 45 (1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034 -75072008000100006&lng=es&nrm=iso&tlng=es [Consultado: 15 de septiembre de 2009].

17. Salcedo Rocha AL, Sánchez Mar M, López Pérez ML, Preciado Soltero HT, Figueroa Suárez PA, Narváez Aguirre VA, et. al. Manifestaciones bucales en pacientes con diabetes mellitus tipo 2, hipertensión y obesidad. Rev Med Inst Mex Seguro Soc. 2006;44(3):203-10.

18. García Mateos MM, Ortiz Urdiain FJ. Manifestaciones orales como primer signo de diabetes mellitus. Semergen. 2004;30:169-74.